Walleye Trading
DNA icon

Walleye Trading’s Ginkgo Bioworks DNA Stock Holding History

Walleye Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,637
Closed -$21.9K – 4255
2025
Q4 		$21.9K Buy
+2,637
New +$28.4K ﹤0.01% 4103
2025
Q1 		– Sell
-2,601
Closed -$25.5K – 4184
2024
Q4 		$25.5K Buy
+2,601
New +$22.3K ﹤0.01% 3915

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's DNA Position: Q1 2026 in Review

Walleye Trading sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 2,637 shares — an estimated $21.9K sold.

Walleye Trading first reported a position in DNA in Q4 2024 and held it in 2 quarters. The position peaked at $25.5K in Q4 2024. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Walleye Trading reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 2,637 Ginkgo Bioworks shares in Q1 2026, an estimated $21.9K.
  • Walleye Trading first reported a position in Ginkgo Bioworks in Q4 2024 and held it in 2 quarters.
  • Walleye Trading's Ginkgo Bioworks position peaked at $25.5K in Q4 2024.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.